The U.S. Food and Drug Administration (FDA) approved Hympavzi (marstacimab-hncq) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients ...
Why are the two often so disconnected? And what role can technology play in integrating them? A new CMS accountable care program aims to drive progress, and one expert explains what it means for ...
The Food and Drug Administration (FDA) has approved Itovebi (inavolisib) with Ibrance (palbociclib) and Faslodex (fulvestrant) for certain patients with advanced or metastatic breast cancer. The Food ...
New hope could be on the horizon for ALS patients in the form of a "breakthrough" drug, researchers say. Neuvivo, a California biopharmaceutical company that develops therapies for ...
SentryBond technology could potentially extend to other medications, though FDA approval is pending. The FDA has approved oxycodone hydrochloride (RoxyBond) for the management of severe pain when ...
The FDA approved Itovebi for people with hormone-sensitive breast cancer that returned while or after taking endocrine therapy, such as the medicine tamoxifen. Itovebi is only approved for people ...
Live Science on MSN1mon
At-home flu vaccine approved by FDA — what to knowA nasal spray version of the annual flu vaccine can now be taken at home, the U.S. Food and Drug Administration (FDA) says.
The US Food and Drug Administration (FDA) has approved AbbVie's VYALEV (foscarbidopa and foslevodopa) to treat motor fluctuations in adults with advanced Parkinson's disease (PD). The chronic ...
The FDA has finally approved the first generic of GlaxoSmithKline’s Advair blockbuster respiratory diseases inhaler, after years of delays. Even though Advair’s main patent expired in 2010 and ...
The trials presented in the application for FDA approval of Enovid as an oral contraceptive were the largest drug trials ever run. In the trials, 897 women had taken 10,427 cycles of the Pill with ...
The product is expected to be available in the first half of 2025. The Food and Drug Administration (FDA) has approved Imuldosa ™ (ustekinumab-srlf), a biosimilar to Stelara ® (ustekinumab ...
Benzinga on MSN3mon
FDA Approves Expanded Use Of Novartis' Rare Disease Drug Fabhalta For Kidney DiseaseOn Thursday, the FDA granted accelerated approval to Novartis AG’s (NYSE:NVS) Fabhalta (iptacopan), a first-in-class ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback